首页> 外文OA文献 >The use of FDG-PET/CT and diffusion-weighted magnetic resonance imaging for response prediction before, during and after preoperative chemoradiotherapy for rectal cancer
【2h】

The use of FDG-PET/CT and diffusion-weighted magnetic resonance imaging for response prediction before, during and after preoperative chemoradiotherapy for rectal cancer

机译:FDG-PET / CT和弥散加权磁共振成像在直肠癌术前放化疗之前,之中和之后的反应预测中的应用

摘要

Purpose. To investigate the use of FDG-PET/CT before, during and after chemoradiotherapy (CRT) and diffusion-weighted magnetic resonance imaging (DW-MRI) before CRT for the prediction of pathological response (pCR) in rectal cancer patients. Material and methods. Twenty-two rectal cancer patients treated with long course CRT were included. An FDG-PET/CT was performed prior to the start of CRT, after 10 to 12 fractions of CRT and five weeks after the end of CRT. The tumor was delineated using a gradient based delineation method and the maximal standardized uptake values (SUVmax) were calculated. A DW-MRI was performed before start of CRT. Mean apparent diffusion coefficients (ADC) were determined. The Delta SUVmax during and after CRT and the initial ADC values were correlated to the histopathological findings after total mesorectal excision (TME). Results. Delta SUVmax during and after CRT significantly correlated with the pathological response to treatment (during CRT: Delta SUVmax = 59% +/- 12% for pCR vs. 25% +/- 27% if no pCR, p = 0.0036; post-CRT: 90% +/- 11 for pCR vs. 63% +/- 22 if no pCR p = 0.013). ROC curve analysis revealed an optimal threshold for Delta SUVmax of 40% during CRT and 76% after CRT. The initial ADC value was also significantly correlated with pCR (0.94 +/- 0.12 x 10(-3) mm(2)/s for pCR vs. 1.2 +/- 0.24 x 10(-3) mm(2)/s, p=0.002) and ROC curve analysis revealed an optimal threshold of 1.06 x 10(-3) mm(2)/s. Combining the provided Delta SUVmax thresholds during and after CRT increased specificity of the prediction (sensitivity 100% and specificity 94%). The combination of the thresholds for the initial ADC value and the Delta SUVmax during CRT increased specificity of the prediction to a similar level (sensitivity of 100% and specificity of 94%). Conclusions. The combination of the different time points and the different imaging modalities increased the specificity of the response assessment both during and after CRT.
机译:目的。目的探讨FDG-PET / CT在放疗前,放疗中和放疗后和放疗前的扩散加权磁共振成像(DW-MRI)在直肠癌患者中预测病理反应(pCR)的用途。材料与方法。包括22例接受长期CRT治疗的直肠癌患者。 FRT-PET / CT在CRT开始之前,CRT分割10至12次之后,CRT结束后五周进行。使用基于梯度的描绘方法描绘肿瘤,并计算最大标准化摄取值(SUVmax)。在开始CRT之前进行了DW-MRI检查。确定平均表观扩散系数(ADC)。 CRT期间和之后的Delta SUVmax和初始ADC值与全直肠系膜切除(TME)后的组织病理学发现相关。结果。 CRT期间和之后的Delta SUVmax与对治疗的病理反应显着相关(CRT期间:pCR的Delta SUVmax = 59%+/- 12%,如果没有pCR则为25%+/- 27%,p = 0.0036; CRT后:pCR为90%+/- 11,而没有pCR则为63%+/- 22(p = 0.013)。 ROC曲线分析显示,CRT期间Delta SUVmax的最佳阈值为40%,CRT之后为76%。 ADC的初始值也与pCR显着相关(pCR为0.94 +/- 0.12 x 10(-3)mm(2)/ s,而1.2 +/- 0.24 x 10(-3)mm(2)/ s p = 0.002)和ROC曲线分析显示最佳阈值为1.06 x 10(-3)mm(2)/ s。在CRT期间和之后,结合提供的Delta SUVmax阈值​​可以提高预测的特异性(敏感性100%和特异性94%)。 CRT期间初始ADC值的阈值和Delta SUVmax的组合将预测的特异性提高到相似的水平(敏感性为100%,特异性为94%)。结论。 CRT期间和之后,不同时间点和不同成像方式的结合提高了反应评估的特异性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号